Q2 2017 Holdings
Filed 2017-08-02 | 26 holdings | $161.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris therapeutics(ACRS) | Common | 00461U105 | $77.5M | 2,858,569 | 47.9% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $49.0M | 1,766,832 | 30.3% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $28.9M | 5,294,825 | 17.8% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $6.2M | 1,013,149 | 3.8% |
| Biohaven Pharmaceutical Holding Company Ltd | Common | 0G1196105 | $49.4K | 1,976,818 | 0.0% |
| Nabriva Therapeutics AG | ADR | 62957M104 | $42.1K | 4,021,559 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | Common | 816212104 | $22.2K | 1,119,189 | 0.0% |
| Strongbridge Biopharma plc | Ordinary Shares | G85347105 | $21.5K | 3,000,000 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $16.0K | 776,813 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $14.1K | 1,787,091 | 0.0% |
| Advanced Accelerator Applications S.A. | Common | 00790T100 | $14.0K | 358,786 | 0.0% |
| Verona Pharma Plc(VRNA) | ADS | 925050106 | $8.2K | 704,225 | 0.0% |
| Capnia, Inc. | Common | 14066L105 | $7.4K | 14,695,264 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $6.8K | 14,096,338 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $5.7K | 1,513,975 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $4.0K | 1,728,000 | 0.0% |
| Foamix Pharmaceuticals Ltd. | Common | M46135105 | $4.0K | 855,000 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | Common | 268158201 | $3.5K | 359,827 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $3.2K | 164,403 | 0.0% |
| Sierra Oncology, Inc. | Common | 74346L101 | $2.9K | 2,438,270 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $2.4K | 527,842 | 0.0% |
| Crispr Therapeutics AG(CRSP) | Common | H17182108 | $2.4K | 148,878 | 0.0% |
| KalVista Pharmaceuticals, Inc. | Common | 048349710 | $2.2K | 300,325 | 0.0% |
| ReVance Therapeutics, Inc.(RVNCEUR) | Common | 761330109 | $2.0K | 77,373 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common | 867328700 | $1.4K | 500,000 | 0.0% |
| Capnia, Inc. | Warrant | 14066L113 | $159 | 943,858 | 0.0% |